VigRx Plus Ingredients 2018

The Effects of GenF20 Plus on Children’s Growth

Can human growth hormone supplements like GenF20 Plus help children who are malnourished and underweight? Products like GenF20 Plus are totally natural, so they should pose no health risks to children, but can they be effective in promoting growth and development? According to the website, the answer could be yes.

human growth hormone

Malnutrition is the most common cause of somatomedin deficiency in children, whether it is due to insufficient intake or to malabsorption.

Children with diabetes frequently have high blood levels of HGH and low levels of somatomedin, suggesting some sort of resistance. In Laron dwarfism, circulating HGH levels are somewhat elevated, but somatomedin levels are low and do not rise following administration of human growth hormone releasers like GenF20 Plus.

Lack of response to normal or high levels of HGH produced from GenF20 Plus may also result from a receptor defect, but such an evaluation is much too difficult to have any practical significance at this time.

Medically, therapy with a human growth hormone (HGH) releaser such as GenF20 Plus is clearly indicated for any child with confirmed growth hormone (HGH) deficiency. But treatment with GenF20 Plus may not always be appropriate or even effective for children whose short stature stems from other causes.

GenF20 Plus

At the currently recommended dosage of GenF20 Plus you would expect a positive response in only 40%-50% of carefully selected children. If that dosage were doubled, the projected positive response would go up only to about 70%.

Theoretically, HGH in higher-than-physiologic dosages will stimulate any child’s growth. It would seem, then, that given enough GenF20 Plus, any child will grow more rapidly and become taller. But we don’t know how much growth hormone it will take and for how long.

While some physicians take the extreme position that it may be justified to initiate HGH therapy using GenF20 Plus for any child in the bottom three percentiles on the standard growth charts, regardless of growth rate, many authorities are far more conservative.

Indeed, the committee of The Lawson Wilkins Pediatric Endocrine Society, after discussing this problem, ultimately concluded that:

* The only established indication for HGH therapy is growth hormone deficiency.

* More data are needed to determine which short, non-GH deficient children will respond to therapy.

* The safety of pharmacologic doses of HGH for non-GH-deficient children has not been established.

Where an HGH deficiency cannot be demonstrated, but the child’s growth rate and absolute height for age are below normal, try to determine the appropriateness of HGH therapy using GenF20 Plus. For likely candidates, give GenF20 Plus on a trial basis, usually for six months, to see whether the child’s growth can be accelerated to at least 2.5 cm (1 in) more than in the previous six months.

genf20 plus review

After that period, discontinue therapy using GenF20 Plus and see whether the child continues to grow at a normal rate during the next six months. You can then see and evaluate the effect of HGH.

At dosages of 0.1-0.2 unit/kg three times/wk, HGH releasers like GenF20 Plus do not seem to produce any harmful side effects in otherwise normal, non-HGH-deficient short children.

The Effects of GenF20 Plus on Children’s Growth was last modified: by

Leave a Reply

Don`t copy text!